Background and aims While mature enterocytes are resistant to transduction by adenovirus type 5 (Ad5) vectors, undifferentiated cells are transduced much more efficiently. Our purpose was to study enterocyte transduction in models of intestinal wound healing.
Introduction
Adenoviruses are valuable gene delivery vectors for manipulation of cellular genes/processes, for both research applications and gene therapy strategies. Adenoviruses are naturally responsible for human respiratory and gastrointestinal infections [1] , suggesting that epithelial cells may be possible targets for recombinant adenoviral vectors. The intestinal epithelium itself presents several advantages as a gene delivery target, such as ease of access via the lumenal route, large tissue mass, increased numbers of rapidly proliferating cells, and access to epithelial stem cells located in the crypts of Lieberkuhn [2, 3] . Local expression of the transgene could prove particularly advantageous for studying or treating gastrointestinal diseases originating in the intestinal wall such as inflammatory bowel disease and colon cancer.
One of the major obstacles to utilizing recombinant adenoviruses for gastrointestinal gene delivery is the relatively low transduction efficiency of mature intestinal epithelial cells by adenoviral vectors as seen both in vitro [4] [5] [6] and in vivo [2] [3] [4] 7] . In vitro studies showed that transduction efficiency of enterocytes was concentrationdependent and inversely correlated with degree of differentiation and cell density [2, [4] [5] [6] . In the case of Caco-2 cells, a human colorectal adenocarcinoma cell line that undergoes spontaneous enterocytic differentiation in culture [8] and is extensively used as a model of small intestinal epithelium, transduction efficiency dramatically decreased after 3 days in culture when cells began to differentiate [5, 6] . Well-differentiated Caco-2 cells that had been more than 2 weeks in culture exhibited extremely low transducibility [5, 6] . IEC-18 cells, which represent a less differentiated crypt celllike phenotype, were transduced more readily [4] . The difference in transduction efficiency at the different stages of differentiation has been partly attributed to the fact that α ν -integrins, known to facilitate the adenovirus internalization process, are more accessible to the virus on the apical membrane in the early stages of differentiation [4, 5] . In vivo studies further confirmed that integrin expression significantly affected gene transfer to the intestinal epithelium [4, 9] . As a result, adenoviral gene delivery to the intestine seems more promising if targeted towards less well-differentiated cells or in cases where epithelial integrity has been impaired.
Restituting intestinal epithelial cells have been shown to exhibit a less well-differentiated phenotype [10] and therefore could be more susceptible to transduction by adenoviral vectors. Utilizing an ex vivo culture system of intestinal biopsies obtained at the time of endoscopy, we observed increased transduction efficiency for a subset of enterocytes with a flattened de-differentiated phenotype, present at the edges of the biopsy. This is the first demonstration of increased transduction of restituting epithelial cells in human tissue. To mimic in vitro the intestinal damage and mucosal wound healing conditions, we used two well-established in vitro models of restituting epithelium and studied differences in adenoviral transduction efficiency between migrating and non-migrating cells. We further carried out transduction inhibition and immunofluorescence experiments to study the role of integrins and CAR (coxsackievirus and adenovirus receptor) in mediating increased transduction in the migrating Caco-2 cells. Differences in CAR expression were observed between migrating and confluent Caco-2 cells. Apically accessible CAR appears to be mediating the transduction of migrating Caco-2 cells. This is in contrast to other epithelial cell models such as airway epithelium where basolaterally localized CAR appears to mediate adenoviral transduction [11] .
Materials and methods

Materials
Tissue culture reagents were obtained from Invitrogen Co. (Carlsbad, CA, USA) and tissue culture materials were from Becton Dickinson (Franklin Lakes, NJ, USA) and Corning Inc. Life Sciences (Acton, MA, USA). The GRGDSP RGD peptide was purchased from Bachem AG (King of Prussia, PA, USA). All other chemicals used were of analytical grade and purchased from Sigma (St. Louis, MO, USA) and Fisher Scientific (Pittsburgh, PA, USA).
Human subjects
These studies were approved by the Institutional Review Board of the University of Michigan Medical Center (IRBMED #1998-0016). All subjects gave informed consent. Endoscopic biopsies from the second portion of the duodenum were obtained from patients undergoing esophagogastroduodenoscopy for clinical indications but whose duodeni appeared endoscopically normal. Exclusion criteria were: age less than 18 years or greater than 65 years, known HIV or viral hepatitis, coagulopathy, use of anticoagulants such as aspirin or coumadin, or inability to give informed consent. Two to six biopsies were obtained from each of seven subjects. mixture (Gibco BRL), and then supplemented to the indicated final concentrations with the following: fetal bovine serum (FBS, 10%; Hyclone, Logan, UT, USA); glucose (10 mM; Abbott Laboratories, N. Chicago, IL, USA); GlutaMax I (2 mM; Gibco BRL); sodium selenite (0.1 µM; Sigma); zinc sulfate (3 µM; Sigma); menadione sodium bisulfite (145 nM; Sigma); vitamin E acetate (45 nM; Sigma or Gibco); sodium penicillin G (100 U/ml; Gibco BRL); and gentamicin (50 µg/ml; Sigma). All components used to supplement the medium were of cell culture quality. Sterile normal saline was placed in the outer well of each organ culture dish to ensure adequate humidity.
Biopsies were transferred from the endoscopic biopsy forceps into sterile transport medium [80% CMRL medium 1066, 20% F-12 (Ham) nutrient mixture] that had been pre-equilibrated with 5% CO 2 in oxygen and kept on ice. After immediate transport to the laboratory, each biopsy was oriented lumenal-side up (with the aid of a dissecting microscope) on a stainless steel screen in an organ culture dish (Falcon, Oxnard, CA, USA) containing 2.15 ml of explant culture medium pre-equilibrated with 5% CO 2 in oxygen. The explants were only partially submerged in this volume of medium. In the biological safety cabinet, 4 µl of a suspension containing 4 × 10 11 particles Ad5CMV-betaGal/ml were applied directly to the upper surface of each explant (1.6 × 10 9 particles per explant). At least two biopsies per patient were used for transduction experiments which were performed on separate occasions on biopsies from seven patients. In preliminary experiments, cultured biopsies (explants) were evaluated for structural integrity and were found to maintain near normal morphology for up to 45 h with identifiable microvilli and tight junctions. Exposure to vectors during the culture period did not affect tissue morphology [16] .
The dishes were then placed on the rack of a modular incubator chamber (Billups Rothenberg Incorporated, Del Mar, CA, USA); open dishes containing water were placed below the rack for humidification. The chamber was gassed with approximately 10 volumes of 5% CO 2 in oxygen over 15 min, then sealed and placed on a rotating table in a 37 • C incubator. The rotating table was turned on (at 40 rpm) 2 h after the application of the vector. The start of gassing occurred approximately 45-60 min from the start of biopsy procurement and was considered 0 h. Explants were kept in culture for 24-28 h at which point transduction was assayed by X-Gal staining.
Cell culture
Caco-2 cells (ATCC HTB37) of passage 33-44 were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% heat-inactivated FBS, 0.1 mM non-essential amino acids (NEAA), 45 nM vitamin E, 100 units/ml penicillin, and 100 µg/ml streptomycin until confluent (typically 3 days). Medium was changed to DMEM with 5% FBS, 0.1 mM NEAA, 45 nM vitamin E, 0.1 µM selenium (Na 2 SeO 3 ), 0.003 nM zinc (ZnSO 4 · 7H 2 O), 100 units/ml penicillin, and 100 µg/ml streptomycin until the end of the experiment (typically 2 weeks). Cells were grown at 37 • C in an atmosphere of 5% CO 2 and 90% relative humidity.
Adenoviral infection studies in the wounded monolayer system
Caco-2 cells were seeded at a density of 4 × 10 5 cells/well on porous collagen-coated polycarbonate cell culture inserts with a pore size of 1 µm and a surface area of 0.9 cm 2 (Corning Inc. Life Sciences) in 12-well plates. Medium was changed every other day for 2 weeks in both apical and basolateral chambers. Differentiated monolayers were mechanically wounded by cutting the monolayer with a cell scraper along one diameter of the insert. Cells were washed with DMEM to remove cell debris and feeding medium was added to both apical and basolateral chambers. Cells were kept in culture for up to 48 h to allow for wound healing to occur. Basolateral medium was renewed while apical medium was replaced with medium containing the desired adenoviral vector(s) at a MOI (multiplicity of infection) of 10, 100, and 1000. After a 2 h incubation at 37 • C, an equal amount of medium was added to the apical chamber and cultures were incubated for 24 or 48 h at 37 • C. At this time, beta-galactosidase expression was assayed with X-Gal staining while luciferase expression was assayed by bioluminescence imaging.
Adenoviral infection studies in the 'fence' system
Caco-2 cells were seeded at a density of 3.33 × 10 5 cells/well in the central opening of stainless steel rings ('fences') placed with the help of an O-ring in the center of the wells of 6-well culture plates or 35 mm culture dishes ('fences' kindly provided by Dr. Jerrold R. Turner, University of Chicago). Cell growth area was 0.79 cm 2 and the volume of cell suspension used was 500 µl. Medium was changed every other day until cells reached a differentiated state. At this point, the 'fence' was removed and new medium was added. Radial monolayer expansion occurs when the 'fence' is lifted from the culture plate [17] . Monolayer expansion was allowed to take place for 24 h after which medium was replaced with adenovirus-containing medium (Ad5CMV or Ad5SHORT; 10, 100 and 1000 MOI). Subsequent steps were similar to the wounded monolayer system. In some studies (conducted at the intermediate MOI of 200), proliferation was first blocked by pre-treatment of the monolayers with 20 µg/ml mitomycin C (Sigma) for 2 h prior to fence removal. This mitomycin C concentration has been shown to be sufficient to arrest cell proliferation in Caco-2 cell cultures [18, 19] .
Adenoviral infection studies in differentiated Caco-2 cells
Caco-2 cells were seeded at a density of 4 × 10 5 cells/well on porous collagen-coated polycarbonate cell culture inserts with a pore size of 1 µm and a surface area of 0.9 cm 2 in 12-well plates. Medium was changed every other day for 2 weeks in both apical and basolateral chambers. Differentiated Caco-2 monolayers were infected with the Ad5CMV-luc(loxP) vector at the desired MOI, either apically or basolaterally. Basolateral transduction was carried out by inverting the culture inserts. Adenovirus transduction was allowed to proceed for 2 h at 37 • C at which point medium was aspirated, replenished with fresh medium, and cells were returned to the incubator. Luminescence activity was assayed after 48 h. In a separate set of experiments, differentiated Caco-2 monolayers were treated with 2.5 mM ethylene glycol tetraacetic acid (EGTA) added to both apical and basolateral chambers for 45 min at 37 • C. This concentration of EGTA has been previously reported to be sufficient to widen the tight junctions in Caco-2 cells [20, 21] . Tight junction widening was confirmed in our studies by a decrease in transepithelial electrical resistance measurements before and after EGTA treatment. Adenoviral infection was subsequently carried out as described above.
X-Gal staining
At the end of the culture period, explants were fixed in 2% formalin in phosphate-buffered saline (PBS) for 2 h, washed twice for 5 min in PBS containing 2 mM magnesium chloride, and placed in X-Gal staining solution [1 mg/ml X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside), 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 2 mM magnesium chloride, 0.01% sodium deoxycholate, 0.02% Nonidet P-40] at 33 • C for 16-18 h. The tissue was then washed twice in PBS and post-fixed in 10% neutral buffered formalin. After 2 h in 10% formalin, the tissue was placed in 30% sucrose/10% formalin for an additional 24 h, then embedded in O.C.T. compound (Miles Inc., Elkhart, IN, USA) and frozen at −80 • C. All steps prior to embedding were carried out on a rotating table at 40-60 rpm.
Sectioning and counterstaining
Sections of the O.C.T.-embedded tissue were prepared with a cryostat and stored at −80 • C. Rehydrated sections of the X-Gal-stained tissue were counterstained with 0.1% Nuclear Fast Red (Sigma; C.I. 60 760) in 5% aluminum sulfate, then dehydrated through a graded series of ethanol, cleared in xylene, and coverslipped with Permount (Fisher Scientific).
Quantitation of X-Gal-stained nuclei
Without magnification, five sections without evidence of folds were chosen from near the center of each explant as judged by largest section size. Consecutive sections were avoided. The morphology of the enterocytes in each section was evaluated microscopically; the presence or absence of columnar enterocytes and attenuated enterocytes (at tissue edges or extending beneath the tissue as a monolayer) was recorded. Note was made of the presence or absence of transduced cells within these subpopulations of enterocytes.
Bioluminescence imaging
At the end of the desired virus incubation time, medium was replaced with feeding medium containing 0.15 or 0.4 mg/ml luciferin and incubated for 30 min at 37 • C. Luciferase expression was quantified as bioluminescence photon counts using a cryogenically cooled Xenogen IVIS  Imaging system (Xenogen Corporation, Alameda, CA, USA) coupled to a data acquisition computer at the Center for Molecular Imaging, University of Michigan. A digital grayscale image was acquired followed by acquisition and overlay of a pseudocolor image representing the spatial distribution of detected photon counts emerging from active luciferase within the wells. Signal intensity was quantified as the sum of all detected photons within the region of interest during a 1 or 3 min luminescent integration time, at level B. Results were expressed as fold photon counts compared to untransduced cells present in the plate.
Adenoviral infection inhibition studies
A mouse monoclonal antibody against human CAR was produced by the Hybridoma Core, University of Michigan, from a commercially available clone (ATCC #CRL-2379) [22] . Infection inhibition studies were carried out using the 'fence' system. Twenty-four hours after 'fence' removal, medium was replaced with blocking medium containing either the monoclonal anti-CAR antibody (ascites fluid 1 : 50, tissue culture supernatant 1 : 1) or an RGD peptide (GRGDSP; 0.4 mM or 1 mM) that blocks integrin binding [4] . Monolayers were incubated with blocking medium for 2 h at room temperature under gentle rotation. Blocking medium was replaced by medium containing the desired MOI of adenoviral vector(s) and plates were moved to the 37 • C incubator to allow for virus infection to occur. After 2 h, vectorcontaining medium was replaced with fresh medium and culture was continued for 48 h before assessing transduction efficiency. The studies were carried out at the submaximal MOI of 200 and at the high MOI of 1000. The two RGD peptide concentrations of 0.4 mM and 1 mM were chosen based on results published on integrinbinding inhibition in differentiated and undifferentiated Caco-2 cells [4] .
Immunofluorescent detection of CAR and cytokeratin
Intestinal explants were stained for cytokeratin and CAR. For cytokeratin staining, archived sections of explants (48 h culture), which had been fixed in 10% neutral buffered formalin for >24 h and embedded in paraffin, were deparaffinized and rehydrated through a graded series of ethanol, then subjected to digestion with pepsin (Zymed, South San Francisco, CA, USA) for 10 min at 37 • C. After washing in PBS, non-specific binding sites were blocked using 2% chicken serum, 1% bovine serum albumin (BSA), 0.1% cold fish skin gelatin, and 0.05% Tween 20 in PBS containing 0.05% sodium azide. The blocking solution was decanted from the sections; then mouse anti-cytokeratin 8 & 18 (Zymed) or MOPC 21 isotype control (both at 5 µg/ml) was applied and incubated for 1 h at room temperature. For CAR staining, sections of explants which had been fixed in 4% paraformaldehyde in PBS for 1 h and embedded in paraffin after infiltration for 2 h at 60 • C were deparaffinized and rehydrated through a graded series of ethanol, then subjected to digestion with proteinase K (Zymed) for 10 min at 37 • C. After washing, ImageiT FX signal enhancer (Molecular Probes, Eugene, OR, USA) was applied for 30 min at room temperature. The sections were again washed and then non-specific binding sites were blocked by incubating with 5% normal chicken serum for 30 min at 37 • C. After a single wash in PBS, sections were incubated with anti-CAR (Upstate Cell Signaling Solutions, Lake Placid, NY, USA) or MOPC 21 isotype control (both at 5 µg/ml in 1% chicken serum in PBS) for 1 h at 37 • C. After washing in PBS, AlexaFluor 488-labeled chicken anti-mouse IgG (1 : 100; Molecular Probes) was applied and incubated for 30 min at room temperature. After washing in PBS, coverslips were applied using ProLong Gold anti-fade mounting medium (Molecular Probes).
For the 'fence' system, 'fences' were placed on top of collagen-coated glass coverslips (Becton Dickinson) placed in 6-well culture plates. Caco-2 cell culture was done as described above for the 'fence' system. Cells were washed with PBS and fixed with 3% paraformaldehyde prior to immunofluorescence staining. In some cases, cells were permeabilized by applying 0.2% Triton X-100 for 15 min. Cells were rinsed with PBS, then blocked with 10% goat serum in PBS for 20 min. Primary antibody was applied (anti-CAR, ascites fluid 1 : 50) for 1-3 h at room temperature. Cells were washed twice with PBS, then fluorescein isothiocyanate (FITC) or AlexaFluor 488 conjugated donkey or goat anti-mouse IgG secondary antibody in 10% goat serum was applied (1 : 100 dilution). Cells were incubated in the dark for 1 h at room temperature. Cells were rinsed twice with PBS, and the coverslips were mounted on glass slides using ProLong mounting medium. Cells were imaged with a Leitz Aristoplan light microscope fitted with a fluorescence filter and equipped with a Diagnostics Spot-RT cooled CCD digital camera.
Data analysis
Statistical significance was determined using Student's t test. p values less than 0.05 were considered statistically significant. Data are shown as mean ± standard error of the mean (SEM).
Results
Adenoviral transduction of intestinal explants
We observed the presence of shortened enterocytes at the edges of several explants (Figure 1 ) occasionally also extending as a monolayer along the bottom of the tissue. The epithelial lineage of the cuboidal cells observed along the bottoms of some explants was confirmed by immunofluorescent staining for cytokeratin ( Figure 1d ). These shortened epithelial cells at the tissue edges were noted to be transduced more frequently by Ad5CMV-betaGal than were normal columnar enterocytes (Figures 1a-1c) .
Columnar epithelial cells were present in all five sections examined from each explant (total 7 subjects, 17 explants, 85 sections); transduction of columnar epithelial cells was observed in four sections (5% of the 85 total occurrences of columnar epithelial cells), representing 3 of the 17 explants and 2 of the 7 subjects. Attenuated (cuboidal to squamoid) epithelial cells were present at explant edges in at least one explant from each of the seven subjects (12 of 17 total explants; 54 of the 85 total sections examined); transduction of attenuated cells at explant edges was observed in at least one section from five of the seven subjects [total of 14 (26%) of the 54 occurrences; total of 6 of the 12 explants in which the morphology was observed]. These attenuated epithelial cells were noted to extend as monolayers beneath at least one explant from five of the seven subjects (8 of 17 total explants; 31 of the 85 total sections examined); transduction of these monolayer cells was observed in explants from three of the five subjects in which monolayer formation was observed [total of 8 (26%) of the 31 occurrences; total of 3 of the 8 explants in which such a monolayer was observed].
Adenoviral transduction in the wounded monolayer system
We compared the transduction efficiency of Ad5CMV-betaGal in repairing (wounded) and non-repairing (nonwounded) Caco-2 cell monolayers. Transduction in the confluent non-wounded monolayers, and in the confluent areas of the wounded monolayers, was low, consistent with prior studies [4, 5] . Migrating (repairing) cells in the wounded monolayers expressed much higher levels of the LacZ reporter gene compared to confluent cultures (Figure 2a ). Transduction increased with time and dose (Figure 2a ). These differences were quantified using bioluminescence imaging after Ad5CMV-luc incubation. As seen in Figure 2b , at the MOI of 1000 there were significantly increased photon counts for wounded monolayers compared to nonwounded monolayers (60.97 ± 3.41 vs. 40.04 ± 6.05 fold untransduced control, p < 0.05).
Adenoviral transduction in the 'fence' system X-Gal staining after Ad5CMV-betaGal transduction showed a similar transduction pattern to that seen in the wounded monolayer system. When monolayers were transduced in their confluent, non-migrating state ('fence' on) there were few transduced cells scattered throughout the culture with only a rare transduced cell observed at the culture edge (Figure 3a, bottom row) . When monolayers were transduced in their migrating state (after 'fence' removal) we saw a much higher number of stained cells (Figure 3a , top row). Transduced cells were localized mainly on the migrating edge of the culture. There was increased transduction at 48 h compared to 24 h (Figure 3a ) with virtually 100% transduction of cells along the leading edge after 48 h at MOI 1000 (shown at lower magnification, Figure 3b) .
Transduction efficiency was quantified using bioluminescence imaging after Ad5CMV-luc infection. There was a time-(24 vs. 48 h) and dose-dependent (MOIs of 0, 100, 1000) increase in transduction efficiency (Figures 4a  and 4b ) for both the non-migrating and migrating state of the monolayer. At corresponding MOIs, the bioluminescent activity observed was much higher in expanding monolayers. Furthermore, photon emission patterns resembled the pattern that was seen with X-Gal staining, in that light emission was higher around the perimeter of the culture (Figure 4c ). The effect was again more pronounced at the high MOI of 1000 (Figure 4c , bottom left well). The effect of cell proliferation on transducibility was studied at the intermediate MOI of 200. As shown in Figure 4d , mitomycin C pre-treatment to arrest cell proliferation in expanding monolayers did not affect transduction efficiency. The difference between expanding and non-expanding monolayers was consistent with the previous experiments.
Apical vs. basolateral adenoviral transduction in Caco-2 monolayers
We compared differences in transduction by Ad5CMV-luc(loxP) after apical vs. basolateral application to Caco-2 monolayers grown on collagen-coated culture inserts. At all MOIs tested apical transduction, while limited, was 4-7-fold higher than basolateral (Figure 5a ). Similar results were obtained with cells grown on uncoated inserts (not shown).
When cells were transduced apically at a MOI of 200 with the Ad5CMV-luc(loxP), EGTA pre-treatment resulted in a 70% increase in bioluminescence activity 
Transduction inhibition experiments
When expanding Caco-2 cell monolayers were preincubated with an anti-CAR antibody (RmcB; 1 : 50 dilution of ascites fluid) and subsequently transduced with Ad5CMV-luc(loxP)/Ad5CMV-betaGal at MOI 200, we observed a 36.5% decrease in transduction efficiency (Figure 6a ). Pre-incubation with a 0.4 mM solution of the RGD peptide resulted in an 18.3% reduction in transduction efficiency (Figure 6a ). Pre-incubation with anti-CAR antibody (1 : 50 dilution of ascites fluid), followed by transduction at the high MOI of 1000, resulted in 39.4% reduction in transduction efficiency (Figure 6b ). However, pre-incubation with the 0.4 mM RGD peptide did not affect adenoviral transduction at this MOI; a significant reduction in transduction (45.4%) was seen when the concentration of the RGD peptide was increased to 1 mM (Figure 6b ). Identical blocking experiments were performed using nonexpanding monolayers which represent fully differentiated Caco-2 cells. At the MOI of 200, pre-incubation with 1 : 50 RmcB ascites fluid reduced transduction levels by 32.2% (Figure 6c ). We noted no inhibition of transduction by the low concentration (0.4 mM) of the RGD peptide. These results were confirmed in experiments with differentiated Caco-2 monolayers grown on collagen-coated cell culture inserts, where RmcB pre-incubation resulted in a similar degree of transduction inhibition while the RGD peptide had a negligible effect (data not shown). However, when the MOI was increased to 1000, neither pre-incubation with the anti-CAR monoclonal antibody or the high concentration of the RGD peptide managed to block transduction (Figure 6d ). Transduction studies with Ad5/Ad41 chimeric vectors expressing the short fiber protein
When non-CAR-binding Ad5SHORT vectors were applied to systems of wounded/migrating Caco-2 cells we noticed a dramatic decrease in transduction efficiency as compared to standard Ad5 vectors. Quantified as bioluminescent activity and shown in Figure 7 for the 'fence' system, at the three MOIs tested (10, 100, 1000) the chimeric vector resulted in 3.5-, 16.5-and 8.8-fold fewer photon counts (fold untransduced control), respectively. The reduced transduction efficiency of these vectors was also confirmed with X-Gal staining, which showed a dramatic decrease in transduced migrating (repairing) cells (data not shown).
Immunofluorescence studies
CAR staining was observed in the apical membrane of enterocytes in the intestinal explants (Figure 8a) . No difference in intensity or localization of CAR immunofluorescent staining was appreciated between columnar enterocytes and attenuated epithelial cells. MOPC isotype controls were negative.
In the Caco-2 cell 'fence' system (Figure 8b ), immunofluorescent staining for CAR in non-permeabilized expanding monolayers ('fence' off, upper panel) was observed in areas of the migrating edge, with limited staining in confluent regions of the cultures. Nonpermeabilized non-expanding monolayers ('fence' on, not shown) showed limited staining throughout. In permeabilized expanding monolayers ('fence' off, middle and lower panels) staining was observed in confluent as well as migrating cells. While confluent areas of the culture showed prominent membrane staining (lower portion of middle panel), staining of cells in the migrating edge (lower panel and upper region of middle panel) appeared to be largely cytoplasmic or perinuclear, with fine membrane staining also present. An intervening region of poorly stained cells was also observed (center portion of middle panel). In contrast, permeabilized confluent monolayers ('fence' on, not shown) showed prominent membrane staining throughout. Omission of primary antibody or staining with a MOPC isotype control resulted in weak background levels of fluorescence. adenoviral vectors and might represent a valid target for the delivery of therapeutic genes to the intestine. The striking increase in transducibility occurs at the leading edge of epithelial cell migration and does not appear to be related to cell proliferation. We demonstrated a significant role of CAR in the increased transducibility of these migrating cells. For these cells, CAR appears to have increased accessibility even to apically applied adenoviral vectors, an observation contrary to previously published reports on other epithelial cell types [11, 23] . Mature, differentiated enterocytes appear to be resistant to transduction by commonly used adenoviral vectors [5, 6] . The same low levels of transduction have been reported for other epithelial cell types such as airway epithelial cells [11, [24] [25] [26] . Studies utilizing Caco-2 cells suggest that the decrease in integrin expression as cells differentiate is responsible for the low transduction efficiency [4, 5] . For airway epithelium, the low transducibility has been attributed to the absence of CAR on the apical cell membrane [11, 25] . Furthermore, it was recently demonstrated that CAR acts as an adhesion molecule mediating homotypic cell-cell contacts, being localized in the apical junction complex helping maintain epithelial integrity [23, 27] . To our knowledge CAR expression has not been studied in intestinal epithelial cells.
Although it is clear that healthy intestinal epithelium offers a poor target for adenoviral vectors, this might not be the case with inflamed or wounded intestinal tissue. Restituting or healing intestinal epithelium occurs in a variety of clinical settings from foreign body or caustic ingestion, to viral gastroenteritis, to chronic inflammation associated with Crohn's disease. Evidence for increased transducibility of damaged intestinal epithelium exists as intrarectal Ad5 administration resulted in higher transgene expression levels in mice with colitis compared with normal mice [28] .
Utilizing an organ culture model, we studied transduction of intestinal epithelium of human endoscopic small intestinal biopsies. Human intestinal explants [29] have been used for a variety of investigations including the effect of insulin on epithelial cell proliferation [30] and the synthesis of brush border membrane proteins [31] . We noted that shortened epithelial cells at the edges of explants had a higher rate of transduction by Ad5CMV-betaGal than did epithelial cells that had maintained a columnar morphology (Figure 1 ). In addition, epithelial cells in damaged areas of epithelium from patients with inflammatory bowel disease are transduced more readily than intact epithelium [16] . The monolayer formation along the lower surface of explants by less differentiated migrating cells is likely analogous to 'outgrowths' of similar poorly differentiated epithelial cells from explants of intestine, nasal polyp, and other tissues when the explants are cultured directly on collagen-coated dishes [32, 33] . Explant outgrowths have been considered to be a model of epithelial regeneration [33] . These data suggest that intestinal epithelial cells with a de-differentiated phenotype, similar to that observed in restituting intestinal epithelium, might represent a better target for adenoviral vectors.
Several models in the literature use migrating or subconfluent Caco-2 cells to model wound healing [34] [35] [36] [37] [38] [39] . The migration characteristics of the Caco-2 cells in these models resemble those seen in vivo [10] . Migrating through the wound as a sheet, they exhibit a less differentiated phenotype with squamous morphology, downregulation of brush border enzymes and integrin, and cytoskeleton reorganization that facilitates cell motility [10] . Two processes are involved in the expansion of the monolayers: cell migration and cell proliferation [18, 19] . To better study the mechanism of the increased transduction of de-differentiated enterocytes we noted in the explant, we utilized two in vitro models of mucosal wound healing: the wounded monolayer and the 'fence'-migration model.
Intestinal epithelial cells are transduced by adenoviral vectors in a dose-and time-dependent manner [5, 6] . This dose dependence was observed for both confluent and expanding monolayers. The most striking differences in transduction efficiency were observed between confluent and expanding monolayers. Expanding monolayers showed up to 3-fold higher transducibility (Figure 4 ) with the majority of the transduced cells present in the migrating edge in both systems (Figures 2 and 3) . Since the migrating cells represent only a small percentage of the total number of cells present in the culture, the observed differences constitute a substantial increase in transgene expression. In fact, at the high MOI of 1000, transduction efficiency of these migrating cells was almost 100% (Figures 2 and 3 ). This is in sharp contrast to the low transducibility observed for confluent differentiated Caco-2 cells both in these studies and in the literature. The high transducibility of this subset of Caco-2 cells suggests that wounded intestinal epithelial cells represent a target that may allow sufficient expression of therapeutic genes delivered by adenoviral vectors.
Seidman et al. reported variations in adenoviral transducibility of lung carcinoma A549 cells during the cell cycle that were associated with changes in the expression of the virus receptor. Virus application during the M phase of the cell cycle resulted in higher transducibility [40] . In the 'fence' system, pre-treatment of expanding monolayers with mitomycin C, an inhibitor of cell proliferation, did not affect the transducibility of the migrating cells (Figure 4d) , suggesting that the mechanism that accounts for their higher transducibility is related to changes that occur during the migration process rather than increased viral gene expression due to the proliferating stage of the cells. CAR and integrins are believed to be the two most important receptors that facilitate adenovirus entry into cells. In the case of Caco-2 cells, a clear role of integrins in the transduction process has been documented [4] and was confirmed in our study. In our study, transduction of non-expanding monolayers was not affected by integrin blocking with the RGD peptide (Figures 6c and 6d) . This is not unexpected given the low level of integrin expression in confluent monolayers [4, 5] . The differences between these data and the slight reduction reported in the literature are probably due to different experimental protocols. We saw a clear inhibition of transduction in expanding monolayers preincubated with the RGD peptide (Figures 6a and 6b) . As cells migrate, cytoskeleton reorganization takes place and integrins are redistributed to the migrating cell surface [10, 41] , thereby making them accessible to the applied adenoviral vectors. It is worth noting that we had to increase RGD peptide concentration from 0.4 mM to 1 mM to achieve inhibition at the high MOI. It is likely that, as almost 100% of cells on the migrating edge get transduced with the increased viral load, a higher concentration of RGD peptide is required to observe significant blocking.
To our knowledge, our data is the first to support a role for CAR in mediating transduction of intestinal epithelial cells. CAR blocking with a monoclonal anti-CAR antibody resulted in reduction of transduction efficiency in expanding monolayers (Figures 6a and 6b) . The level of blocking observed at the MOI of 200 was similar to that observed for non-expanding monolayers. However, at the MOI of 1000, while CAR blocking did not affect non-expanding monolayers, expanding monolayers were affected to the same extent as at the MOI of 200. We hypothesize that the reduced transduction after anti-CAR mAb preincubation is due to increased interactions between CAR on the surface of the migrating cells and the applied viruses. The fact that we see significant inhibition of transduction of non-expanding monolayers is a little surprising since CAR has been suggested to be localized either basally or at the tight junction complex towards the apical pole of the lateral membrane [27, 42, 43] . Previous studies have shown that airway epithelia [11] show higher transduction efficiency from the basolateral side. Our transduction inhibition data suggest that, in Caco-2 cells, CAR is accessible to adenovirus even after apical application of the virus ( Figure 6 ). Furthermore, our studies comparing apical to basolateral transduction of differentiated Caco-2 cells showed an opposite pattern to other epithelial cell lines, with significantly higher apical transduction ( Figure 5 ). Higher apical transduction of Caco-2 cells has been previously reported [6] . Disruption of the tight junctions led to a modest increase (less than 2-fold) in transduction efficiency ( Figure 5) , consistent with the observation in Caco-2 cells that apical interactions between the cell surface and receptors are favored over basolateral ones. Similar treatment in airway epithelium has been reported to lead to an 8-9-fold increase in transduction efficiency [11] , suggesting that, in airway epithelium, the virus selectively binds to receptors on the basolateral surface. To our knowledge, this is the first study to demonstrate that in an epithelial cell line, CAR is accessible from the apical surface. Although the overall transduction is still limited, this finding supports the concept of lumenal delivery of adenovirus to the intestine via the oral route.
The results obtained with the chimeric Ad5/Ad41 vector further support a higher accessibility of CAR in cells on the migrating edge of expanding Caco-2 cultures. Ad41 is a subgroup F enterotropic adenovirus with significant structural differences compared to Ad5. The most notable of these is that Ad41 particles carry two fibers of different lengths and different primary sequences, designated the long and short fiber [44] . The short fiber has been shown to be unable to bind to CAR or block adenoviral transduction in culture [45] . As a result, Ad5SHORT vectors that carry the short fiber of Ad41 on their capsid are unable to initiate transduction by binding to CAR. We observed a dramatic decrease in transduction efficiency of the chimeric vectors compared to the parent Ad5 vector in both confluent ( Figure 5 ) and expanding ( Figure 7 ) Caco-2 monolayers. In the latter, the majority of Ad5 transduction occurs in the migrating cells at the edge of the culture. As the chimeric vectors do not bind CAR, the overall level of transgene expression in expanding monolayers transduced with these vectors is significantly lower than that observed with Ad5.
Immunofluorescence studies demonstrated increased CAR immunoreactivity in the cells at the migrating edge of non-permeabilized Caco-2 monolayers as compared to areas of confluence (Figure 8b ). The role of CAR in the increased transduction of the migrating cells could be due to either increased CAR expression or redistribution of existing CAR receptors on the cell surface. Permeabilized monolayers showed increased staining intensity and a somewhat different pattern of staining, with prominent membrane staining in confluent areas and increased cytoplasmic/perinuclear staining in migrating cells, which also retained fine membrane staining. Because membrane staining of differentiated Caco-2 cells by anti-CAR was not well seen unless the monolayers were permeabilized, the epitope of the transmembrane CAR protein that is recognized by the antibody appears to reside predominantly intracellularly or in the transmembrane domain in differentiated Caco-2 cells. The observation of prominent staining of migrating cells at the edges of non-permeabilized monolayers suggests a reorientation plus/minus redistribution of CAR protein in this cell population. The intracellular staining of permeabilized migrating cells suggests that there may also be increased CAR synthesis. Although there are no available data on Caco-2 cells, differentiated and undifferentiated airway epithelial cells have been shown to express similar levels of CAR mRNA [11] . It has been reported that, during epithelial migration, there are changes in the cellular distribution of cytoskeleton proteins and adhesion molecules, such as integrins [10, 41] . Since CAR is a cell-cell adhesion molecule normally present at the tight junction complex, it might also be undergoing cellular redistribution thus being more accessible to viral vectors on the cell surface of the restituting cells during intestinal wound healing. A role of CAR in the migration/restitution process has been suggested in other organs including the nervous system [46] , the heart [47] , and the carotid artery [48] .
Immunofluorescence studies in explant cultures demonstrated CAR immunoreactivity in the apical membranes of both columnar and cuboidal enterocytes. We were unable to demonstrate a difference in intensity or localization of CAR immunofluorescent staining between the columnar and attenuated epithelial cells. However, this may reflect the limitations of quantitation by this technique and the fact that the tissue was in effect 'permeabilized' by sectioning as well as by xylene deparaffinization. The lack of cytoplasmic or perinuclear CAR staining in the attenuated epithelial cells may reflect the difficulty in the explant model of capturing epithelial cells which are truly of the migrating (leading edge) phenotype.
In summary, using human intestinal biopsy cultures and in vitro models of intestinal epithelial wound healing we have demonstrated that migrating intestinal epithelial cells with a de-differentiated phenotype are transduced much more efficiently than normal, fully differentiated cells. The effect appears to be related to integrin and CAR expression by the migrating cells that is associated with the migration process and is not coupled with the proliferative state of the cells. Our data is consistent with greater accessibility of CAR on the cell surface rather than increased access of the virus to the basolateral surfaces of the cells. The involvement of integrins in transduction of migrating epithelial cells is consistent with literature data that show reorganization of the cytoskeleton and integrin redistribution during the migration process of Caco-2 cells. The novel finding here is the significant role of CAR in mediating the increased transducibility of migrating cells possibly related to receptor redistribution occurring during migration. The flattened intestinal epithelial cells of the explants and the migrating Caco-2 cells in the in vitro models used in this study are similar to restituting intestinal epithelial cells seen in vivo in inflamed or damaged tissue. As a result, these cells might represent a therapeutic target for adenoviral vectors in intestinal diseases where healing of damaged tissue occurs, such as radiationinduced intestinal injury or inflammatory bowel disease.
